Literature DB >> 30001480

Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells.

Stefano Gambera1, Ander Abarrategi1,2, Miguel A Rodríguez-Milla1, Francisca Mulero3, Sofía T Menéndez4,5, René Rodriguez4,5, Samuel Navarro5,6, Javier García-Castro1.   

Abstract

Osteosarcoma (OS) is a highly aggressive bone tumor that usually arises intramedullary at the extremities of long bones. Due to the fact that the peak of incidence is in the growth spurt of adolescence, the specific anatomical location, and the heterogeneity of cells, it is believed that osteosarcomagenesis is a process associated with bone development. Different studies in murine models showed that the tumor-initiating cell in OS could be an uncommitted mesenchymal stem cell (MSC) developing in a specific bone microenvironment. However, only a few studies have reported transgene-induced human MSCs transformation and mostly obtained undifferentiated sarcomas. In our study, we demonstrate that activator protein 1 family members induce osteosarcomagenesis in immortalized hMSC. c-JUN or c-JUN/c-FOS overexpression act as tumorigenic factors generating OS with fibroblastic or pleomorphic osteoblastic phenotypes, respectively. Stem Cells 2018;36:1487-1500.
© 2018 The Authors Stem Cells published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

Entities:  

Keywords:  Mesenchymal stem cells; Osteosarcoma; Rbc-JUN; c-FOS; p53

Mesh:

Substances:

Year:  2018        PMID: 30001480     DOI: 10.1002/stem.2869

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  8 in total

1.  Proof of concept for the use of trained sniffer dogs to detect osteosarcoma.

Authors:  Agustín Ortal; Aida Rodríguez; María Pilar Solis-Hernández; Miguel de Prado; Verónica Rey; Juan Tornín; Óscar Estupiñán; Borja Gallego; Dzohara Murillo; Carmen Huergo; Juan Luis García-Llano; Serafín Costilla; René Rodríguez
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

2.  Usefulness of Mesenchymal Cell Lines for Bone and Cartilage Regeneration Research.

Authors:  M Piñeiro-Ramil; C Sanjurjo-Rodríguez; R Castro-Viñuelas; S Rodríguez-Fernández; I M Fuentes-Boquete; F J Blanco; S M Díaz-Prado
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

3.  Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.

Authors:  Ankai Xu; Chao Qian; Jinti Lin; Wei Yu; Jiakang Jin; Bing Liu; Huimin Tao
Journal:  Genes (Basel)       Date:  2021-10-23       Impact factor: 4.096

Review 4.  TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.

Authors:  Zhenghou Zhang; Xiangyu Zhou; Jinshuai Guo; Fusheng Zhang; Yiping Qian; Guang Wang; Meiqi Duan; Yutian Wang; Haiying Zhao; Zhi Yang; Zunpeng Liu; Xiaofeng Jiang
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

5.  Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models.

Authors:  Borja Gallego; Dzohara Murillo; Verónica Rey; Carmen Huergo; Óscar Estupiñán; Aida Rodríguez; Juan Tornín; René Rodríguez
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

6.  Evidence for AJUBA-catenin-CDH4-linked differentiation resistance of mesenchymal stem cells implies tumorigenesis and progression of head and neck squamous cell carcinoma: a single-cell transcriptome approach.

Authors:  Andres Stucky; Li Gao; Lan Sun; Shengwen Calvin Li; Xuelian Chen; Tiffany H Park; Jin Cai; Mustafa H Kabeer; Xi Zhang; Uttam K Sinha; Jiang F Zhong
Journal:  Blood Genom       Date:  2021

7.  The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma.

Authors:  Tianyu Feng; Zhongkai Zhu; Yaqian Jin; Hao Wang; Xiaohan Mao; Dan Liu; Yiling Li; Lixia Lu; Guowei Zuo
Journal:  Oncol Rep       Date:  2019-12-31       Impact factor: 3.906

Review 8.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.